Identification of Inqovi:

No description

Search images on Google      Product Monograph

Active Ingredients:

• decitabine, 35 MG
• cedazuridine, 100 MG

DIN: 02501600

Dosage Form(s): TABLET

Route(s) of Administration: ORAL

Schedule: Prescription

Company: OTSUKA PHARMACEUTICAL CO LTD

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01B - ANTIMETABOLITES (ATC, WHO)
• L01BC - Pyrimidine analogues (ATC, WHO)
• L01BC58 - DECITABINE, COMBINATIONS (WHO)

 

External Links for Inqovi:

Search on Google

• Inqovi side effects
• Inqovi dosage
• decitabine side effects
• decitabine dosage
• cedazuridine side effects
• cedazuridine dosage